-
Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
Tuesday, March 21, 2023 - 3:52pm | 546Psyence Partners with iNGENū for Palliative Care Clinical Trial Life sciences biotech company Psyence Group Inc (OTCQB: PSYGF)’s wholly-owned Australian subsidiary Psyence Australia Pty Ltd. partnered with Contract Research Organization (CRO) iNGENū Pty Ltd to conduct a Phase 2b clinical...